Evidence for A Depressor Action of At1 Receptors in the Nucleus of the Solitary Tract (Nts)

Ying Dong,Zhiying Shan,Peng Shi,Mohan K. Raizada,Colin Sumners
DOI: https://doi.org/10.1096/fasebj.24.1_supplement.809.11
2010-01-01
Abstract:The NTS contains angiotensin II (Ang II) type 1 receptors (AT1R) and their levels are increased in spontaneously hypertensive rats (SHR). However, the precise roles of AT1R in this cardiovascular control center are not established. Here we investigated the cardiovascular effects of AAV2‐U6‐AT1R‐shRNA‐mediated knockdown AT1R in the NTS of SHR. Incubation of rat brainstem neurons in culture with this vector (2×1012gc/ml) decreased AT1aR and AT1bR mRNAs levels by 72% and 68% respectively compared with the control vector AAV2‐U6‐SCR‐shRNA. In vivo, microinjection of AT1R‐shRNA or SCR‐shRNA bilaterally into the NTS of 6 week old SHR (n=3 each group), produced no immediate changes in basal mean arterial blood pressure (MAP) and heart rate (HR), recorded via radiotelemetry. Basal MAP was 120.1 ± 2.11 and 120.5 ± 4.95 mmHg respectively in AT1R‐shRNA and SCR‐shRNA‐injected rats, during the light phase. By 44 days after the microinjections, basal MAP was significantly greater (p<0.05) in the AT1R‐shRNA‐injected SHR (Light phase 167.4 ± 13.73 mmHg; Dark phase 180.9 ± 11.90 mmHg) compared with the controls (Light phase 144.3 ± 6.22; Dark phase 154.1 ± 4.36 mmHg). HR was not different between the two groups at any of the time points. Since AT1R‐shRNA is expected to reduce AT1R levels in the NTS, these data suggest that certain of the AT1R within NTS mediate a depressor action of Ang II. Supported by NIH grants HL‐076803 and HL‐033610.
What problem does this paper attempt to address?